Cargando…
Diabetes, use of metformin, and the risk of meningioma
BACKGROUND: Metformin is a commonly used oral antidiabetic agent that has been associated with decreased cancer risk. However, data regarding the association between metformin use and the risk of meningioma are unavailable. METHODS: We conducted a matched case-control analysis using data from the U....
Autores principales: | Seliger, Corinna, Meier, Christoph R., Becker, Claudia, Jick, Susan S., Proescholdt, Martin, Bogdahn, Ulrich, Hau, Peter, Leitzmann, Michael F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510861/ https://www.ncbi.nlm.nih.gov/pubmed/28708856 http://dx.doi.org/10.1371/journal.pone.0181089 |
Ejemplares similares
-
Metabolic syndrome in relation to risk of meningioma
por: Seliger, Corinna, et al.
Publicado: (2016) -
Use of Selective Cyclooxygenase-2 Inhibitors, Other Analgesics, and Risk of Glioma
por: Seliger, Corinna, et al.
Publicado: (2016) -
Antimicrobial drug use and the risk of glioma: A case–control study
por: Haedenkamp, Tareq M., et al.
Publicado: (2022) -
Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma
por: Anssar, Tareq M., et al.
Publicado: (2019) -
Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation
por: Leidgens, Verena, et al.
Publicado: (2016)